Imiquimod
- 30 April 2003
- journal article
- review article
- Published by Elsevier BV in Dermatologic Clinics
- Vol. 21 (2), 291-300
- https://doi.org/10.1016/s0733-8635(02)00094-3
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Successful Treatment of Drug‐Resistant Cutaneous Leishmaniasis in Humans by Use of Imiquimod, an ImmunomodulatorClinical Infectious Diseases, 2001
- Treatment of Anogenital Warts in Children with Topical 0.05% Podofilox Gel and 5% Imiquimod CreamPediatric Dermatology, 2001
- Toll receptors and sepsisCurrent Opinion in Critical Care, 2001
- Self-administered topical 5% imiquimod cream for external anogenital warts in adolescent girlsPublished by Ovid Technologies (Wolters Kluwer Health) ,2001
- Successful Treatment of Extensive Condyloma Acuminata of the Inguinal Area and Thigh with Topical Imiquimod CreamActa Dermato-Venereologica, 2001
- The Imidazoquinolines, Imiquimod and R-848, Induce Functional, but Not Phenotypic, Maturation of Human Epidermal Langerhans' CellsClinical Immunology, 2000
- Attenuation of virus-induced airway dysfunction in rats treated with imiquimodEuropean Respiratory Journal, 1998
- Immunomodulating and antiviral activities of the imidazoquinoline S-28463Antiviral Research, 1995
- Interleukin-12 and its role in the generation of TH1 cellsImmunology Today, 1993
- Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced MacrophagesScience, 1993